Showing 121 - 131 results of 131 for search 'Pellagatti, A', query time: 1.68s
Refine Results
-
121
BCL-2 inhibitor ABT-737 effectively targets leukemia-initiating cells with differential regulation of relevant genes leading to extended survival in a NRAS/BCL-2 mouse model of hig... by Gorombei, P, Guidez, F, Ganesan, S, Chiquet, M, Pellagatti, A, Goursaud, L, Tekin, N, Beurlet, S, Patel, S, Guerenne, L, Le Pogam, C, Setterblad, N, de la Grange, P, LeBoeuf, C, Janin, A, Noguera, M-E, Sarda-Mantel, L, Merlet, P, Boultwood, J, Konopleva, M, Andreeff, M, West, R, Pla, M, Adès, L, Fenaux, P, Krief, P, Chomienne, C, Omidvar, N, Padua, RA
Published 2021Journal article -
122
GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome (MDS) by Botezatu, L, Michel, L, Makishima, H, Schroeder, T, Germing, U, Haas, R, van der Reijden, B, Marneth, A, Bergevoet, S, Jansen, J, Przychodzen, B, Wlodarski, M, Niemeyer, C, Platzbecker, U, Ehninger, G, Unnikrishnan, A, Beck, D, Pimanda, J, Hellström-Lindberg, E, Cazzola, M, Malcovati, L, Boultwood, J, Pellagatti, A, Papaemmanuil, E, Le Coutre, P, Kaeda, J, Opalka, B, Möröy, T, Dührsen, U, Maciejewski, J, Khandanpour, C
Published 2016Journal article -
123
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells by Shastri, A, Choudhary, G, Teixeira, M, Gordon-Mitchell, S, Ramachandra, N, Bernard, L, Bhattacharyya, S, Lopez, R, Pradhan, K, Giricz, O, Ravipati, G, Wong, L, Cole, S, Bhagat, T, Feld, J, Dhar, Y, Bartenstein, M, Thiruthuvanathan, V, Wickrema, A, Ye, B, Frank, D, Pellagatti, A, Boultwood, J, Zhou, T, Kim, Y, Macleod, A, Epling-Burnette, P, Ye, M, McCoon, P, Woessner, R, Steidl, U, Will, B, Verma, A
Published 2018Journal article -
124
SIRT1 activation disrupts maintenance of Myelodysplastic syndrome stem and Progenitor cells by restoring TET2 function by Sun, J, He, X, Zhu, Y, Ding, Z, Dong, H, Feng, Y, Du, J, Wang, H, Wu, X, Zhang, L, Yu, X, Lin, A, McDonald, T, Zhao, D, Wu, H, Hua, W, Zhang, B, Feng, L, Tohyama, K, Bhatia, R, Oberdoerffer, P, Chung, Y, Aplan, P, Boultwood, J, Pellagatti, A, Khaled, S, Kortylewski, M, Pichiorri, F, Kuo, Y, Carlesso, N, Marcucci, G, Jin, H, Li, L
Published 2018Journal article -
125
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS by Malcovati, L, Stevenson, K, Papaemmanuil, E, Neuberg, D, Bejar, R, Boultwood, J, Bowen, DT, Campbell, PJ, Ebert, BL, Fenaux, P, Haferlach, T, Heuser, M, Jansen, JH, Komrokji, RS, Maciejewski, JP, Walter, MJ, Fontenay, M, Garcia-Manero, G, Graubert, TA, Karsan, A, Meggendorfer, M, Pellagatti, A, Sallman, DA, Savona, MR, Sekeres, M, Steensma, DP, Tauro, S, Thol, F, Vyas, P, Van de Loosdrecht, AA, Haase, DT, Tuechler, H, Greenberg, PL, Ogawa, S, Hellstrom-Lindberg, ES, Cazzola, M
Published 2020Journal article -
126
Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome by Bhagat, T, Chen, S, Bartenstein, M, Barlowe, TS, von Ahrens, D, Choudhary, GS, Tivnan, P, Amin, E, Marcondes, AM, Sanders, MA, Hoogenboezem, RM, Kambhampati, S, Ramachandra, N, Mantzaris, I, Sukrithan, V, Laurence, R, Lopez, R, Bhagat, P, Giricz, O, Sohal, D, Wickrema, A, Yeung, CC, Gritsman, K, Aplan, PD, Hochedlinger, K, Yu, Y, Pradhan, K, Zhang, J, Greally, J, Mukherjee, S, Pellagatti, A, Boultwood, J, Will, B, Steidl, U, Raaijmakers, MH, Deeg, HJ, Kharas, MG, Verma, A
Published 2017Journal article -
127
Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes by Unnikrishnan, A, Deshpande, NP, Verma, A, Kumari, A, Richards, LA, Knezevic, K, Chandrakanthan, V, Thoms, JAI, Tursky, ML, Huang, Y, Ali, Z, Olivier, J, Galbraith, S, Kulasekararaj, AG, Tobiasson, M, Karimi, M, Pellagatti, A, Wilson, SR, Lindeman, R, Young, B, Ramakrishna, R, Arthur, C, Stark, R, Crispin, P, Curnow, J, Warburton, P, Roncolato, F, Boultwood, J, Lynch, K, Jacobsen, SEW, Mufti, GJ, Hellstrom-Lindberg, E, Wilkins, MR, MacKenzie, KL, Wong, JWH, Campbell, PJ, Pimanda, JE
Published 2017Journal article -
128
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. by Woll, P, Kjällquist, U, Chowdhury, O, Doolittle, H, Wedge, D, Thongjuea, S, Erlandsson, R, Ngara, M, Anderson, K, Deng, Q, Mead, A, Stenson, L, Giustacchini, A, Duarte, S, Giannoulatou, E, Taylor, S, Karimi, M, Scharenberg, C, Mortera-Blanco, T, Macaulay, I, Clark, SA, Dybedal, I, Josefsen, D, Fenaux, P, Hokland, P, Holm, MS, Cazzola, M, Malcovati, L, Tauro, S, Bowen, D, Boultwood, J, Pellagatti, A, Pimanda, J, Unnikrishnan, A, Vyas, P, Göhring, G, Schlegelberger, B, Tobiasson, M, Kvalheim, G, Constantinescu, SN, Nerlov, C, Nilsson, L, Campbell, P, Sandberg, R, Papaemmanuil, E, Hellström-Lindberg, E, Linnarsson, S, Jacobsen, S
Published 2014Journal article -
129
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups by Haase, D, Stevenson, KE, Neuberg, D, Maciejewski, JP, Nazha, A, Sekeres, MA, Ebert, BL, Garcia-Manero, G, Haferlach, C, Haferlach, T, Kern, W, Ogawa, S, Nagata, Y, Yoshida, K, Graubert, TA, Walter, MJ, List, AF, Komrokji, RS, Padron, E, Sallman, D, Papaemmanuil, E, Campbell, PJ, Savona, MR, Seegmiller, A, Adès, L, Fenaux, P, Shih, L-Y, Bowen, D, Groves, MJ, Tauro, S, Fontenay, M, Kosmider, O, Bar-Natan, M, Steensma, D, Stone, R, Heuser, M, Thol, F, Cazzola, M, Malcovati, L, Karsan, A, Ganster, C, Hellström-Lindberg, E, Boultwood, J, Pellagatti, A, Santini, V, Quek, L, Vyas, P, Tüchler, H, Greenberg, PL, Bejar, R, International Working Group For Mds Molecular Prognostic Committee
Published 2019Journal article -
130
An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes by Lee, J
Published 2022Other Authors: “…Pellagatti, A…”
Thesis -
131
Identification of new therapeutic targets and drug repositioning in myelodysplastic syndromes using transcriptional profiling and connectivity mapping by Sun, T
Published 2021Other Authors: “…Pellagatti, A…”
Thesis